loadpatents
name:-0.043044090270996
name:-0.019630908966064
name:-0.0041079521179199
Hollingworth; Gregory John Patent Filings

Hollingworth; Gregory John

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hollingworth; Gregory John.The latest application filed is for "tetrahydro-pyrido-pyrimidine derivatives".

Company Profile
4.18.35
  • Hollingworth; Gregory John - Horsham GB
  • Hollingworth; Gregory John - Kent GB
  • Hollingworth; Gregory John - Brentwood GB
  • Hollingworth; Gregory John -
  • Hollingworth; Gregory John - Basildon GB
  • Hollingworth; Gregory John - Harlow GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Tetrahydro-Pyrido-Pyrimidine Derivatives
App 20220267318 - Cooke; Nigel Graham ;   et al.
2022-08-25
3-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carbo- xamide Derivatives
App 20210251996 - Arista; Luca ;   et al.
2021-08-19
N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)benzamide Derivatives
App 20210002285 - Arista; Luca ;   et al.
2021-01-07
Tetrahydro-Pyrido-Pyrimidine Derivatives
App 20200392132 - Cooke; Nigel Graham ;   et al.
2020-12-17
Tetrahydro-Pyrido-Pyrimidine Derivatives as PI3Kdelta inhibitors
App 20190218217 - Cooke; Nigel Graham ;   et al.
2019-07-18
Tetrahydro-Pyrido-Pyrimidine Derivatives
App 20190040061 - Cooke; Nigel Graham ;   et al.
2019-02-07
Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors
Grant 10,112,926 - Bellenie , et al. October 30, 2
2018-10-30
Tetrahydro-Pyrido-Pyrimidine Derivatives
App 20180265509 - Cooke; Nigel Graham ;   et al.
2018-09-20
Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
App 20180243297 - Bellenie; Benjamin Richard ;   et al.
2018-08-30
Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
Grant 10,004,732 - Bellenie , et al. June 26, 2
2018-06-26
Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
Grant 9,862,711 - Bellenie , et al. January 9, 2
2018-01-09
Tetrahydro-Pyrido-Pyrimidine Derivatives
App 20170267678 - COOKE; Nigel Graham ;   et al.
2017-09-21
Amino Pyrazine Derivatives As Phosphatidylinositol 3-kinase Inhibitors
App 20170042889 - BELLENIE; Benjamin Richard ;   et al.
2017-02-16
Amino Pyridine Derivatives As Phosphatidylinositol 3-kinase Inhibitors
App 20170037032 - BELLENIE; Benjamin Richard ;   et al.
2017-02-09
Pyrazine Derivatives As Phosphatidylinositol 3-kinase Inhibitors
App 20170029414 - BELLENIE; Benjamin Richard ;   et al.
2017-02-02
Tetrahydro-Pyrido-Pyrimidine Derivatives
App 20170022199 - COOKE; Nigel Graham ;   et al.
2017-01-26
Tetrahydro-pyrido-pyrimidine derivatives
Grant 9,499,536 - Cooke , et al. November 22, 2
2016-11-22
Tetrahydro-Pyrido-Pyrimidine Derivatives
App 20140128370 - COOKE; Nigel Graham ;   et al.
2014-05-08
Tetrahydro-Pyrido-Pyrimidine Derivatives
App 20120065183 - COOKE; Nigel Graham ;   et al.
2012-03-15
2,3-Substituted Fused Pyrimidin -4 (3H)-Ones as VR1 Antagonists
App 20110152242 - Bayliss; Tracy ;   et al.
2011-06-23
2,3-Substituted fused bicyclic pyrimidin-4(3H)-ones which modulating the function of the vanilloid -1 receptor (VR1)
App 20090233947 - Bayliss; Tracy ;   et al.
2009-09-17
Amino-heterocycles as VR-1 antagonists for treating pain
Grant 7,442,701 - Blurton , et al. October 28, 2
2008-10-28
Heteroaromatic urea derivatives as VR-1 receptor modulators for treating pain
Grant 7,285,563 - Brown , et al. October 23, 2
2007-10-23
Prodrugs Of Substituted Amino Heterobicycles Which Modulate The Function Of The Vanilloid-1 Receptor (Vr1)
App 20070213332 - Burkamp; Frank ;   et al.
2007-09-13
Gem-disubstituted cyclohexane derivatives and their use as therapeutic agents
Grant 7,253,205 - Castro Pineiro , et al. August 7, 2
2007-08-07
Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1)
App 20070135454 - Bayliss; Tracy ;   et al.
2007-06-14
Derivatives of n-(1h-indazolyl)-and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for treatment of pain
App 20070078156 - Fletcher; Stephen Robert ;   et al.
2007-04-05
Cyclohexane derivatives and their use as therapeutic agents
Grant 7,105,507 - Castro Pineiro , et al. September 12, 2
2006-09-12
Substituted amino heterocycles as vr-1 antagonists for treating pain
App 20060154930 - Brown; Rebecca Elizabeth ;   et al.
2006-07-13
Amino-heterocycles as vr-1 antagonists for treating pain
App 20060040947 - Blurton; Peter ;   et al.
2006-02-23
Cyclohexyl derivatives and their use as therapeutic agents
Grant 6,953,792 - Castro Pineiro , et al. October 11, 2
2005-10-11
Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain
App 20050197342 - Hollingworth, Gregory John ;   et al.
2005-09-08
Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain
App 20050107388 - Brown, Rebecca Elizabeth ;   et al.
2005-05-19
Gem-disubstituted cyclohexane derivatives and their use as therapeutic agents
App 20040171642 - Pineiro, Jose Luis Castro ;   et al.
2004-09-02
Cyclohexane derivatives and their use as therapeutic agents
App 20030236250 - Castro Pineiro, Jose Luis ;   et al.
2003-12-25
Cyclohexyl derivatives and their use as therapeutic agents
App 20030225059 - Pineiro, Jose Luis Castro ;   et al.
2003-12-04
Use of NK-1 receptor antagonists for treating major depressive disorders
Grant 6,613,765 - Baker , et al. September 2, 2
2003-09-02
2-aryl indole derivative as antagonists of tachykinins
Grant 6,518,273 - Chapman , et al. February 11, 2
2003-02-11
Azaindole derivatives and their use as therapeutic agents
App 20020022624 - Dinnell, Kevin ;   et al.
2002-02-21
2-aryl indole derivatives and their use as therapeutic agents
App 20010039286 - Dinnell, Kevin ;   et al.
2001-11-08
Spiro-azacyclic derivatives and their use as therapeutic agents
Grant 6,172,077 - Curtis , et al. January 9, 2
2001-01-09
Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety
Grant 6,114,315 - Baker , et al. September 5, 2
2000-09-05
Spiro-piperidine derivatives and their use as therapeutic agents
Grant 6,071,927 - Baker , et al. June 6, 2
2000-06-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed